Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 63.60M | $ 41.80M | $ 87.00M | $ 60.80M | $ 109.60M |
Total Assets | $ 1.36B | $ 1.28B | $ 1.13B | $ 1.08B | $ 1.12B |
Total Debt | $ 414.00M | $ 391.20M | $ 324.80M | $ 344.50M | $ 381.20M |
Net Debt | $ 350.40M | $ 349.40M | $ 237.80M | $ 283.70M | $ 271.60M |
Total Liabilities | $ 793.10M | $ 727.10M | $ 656.70M | $ 663.80M | $ 711.40M |
Stockholders Equity | $ 564.60M | $ 551.00M | $ 470.40M | $ 417.80M | $ 408.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |